Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Submitted by
admin
on October 26, 2011 - 9:11am
Source:
Fierce Biotech
News Tags:
Teva Pharmaceuticals
multiple sclerosis
MS
Copaxone
Biogen
BG-12
Headline:
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Do Not Allow Advertisers to Use My Personal information
